Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F2α synthesis through adipose triglyceride lipase/calcium-independent phospholipase A2

Arthritis and Rheumatism

Volumn 65, Issue 2, 2013, Pages 492-502

  Kanno, Yosuke ^a   Kawashita, Eri ^a   Kokado, Akiko ^a   Okada, Kiyotaka ^b   Ueshima, Shigeru ^b,c   Matsuo, Osamu ^b   Matsuno, Hiroyuki ^a  

^a DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KINKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLEOMYCIN; CALCIUM; COLLAGEN; PHOSPHATE BUFFERED SALINE; PHOSPHOLIPASE A2; PROSTAGLANDIN F2 ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL LIPASE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SKIN FIBROSIS; SKINFOLD THICKNESS; SYSTEMIC SCLEROSIS; WESTERN BLOTTING;

ALPHA-2-ANTIPLASMIN; ANIMALS; BLEOMYCIN; CELLS, CULTURED; COLLAGEN; DINOPROST; DINOPROSTONE; DISEASE MODELS, ANIMAL; FIBROBLASTS; FIBROSIS; LIPASE; MICE; PHOSPHOLIPASES A2, CALCIUM-INDEPENDENT; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; SKIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84873877293     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37767     Document Type: Article

References (39)

1. Border WA, Noble NA,. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331: 1286-92.
2. Collen D,. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. Eur J Biochem 1976; 69: 209-16.
3. Lijnen HR, De Cock F, Van Hoef B, Schlott B, Collen D,. Characterization of the interaction between plasminogen and staphylokinase. Eur J Biochem 1994; 224: 143-9.
4. Yagame M, Eguchi K, Suzuki D, Machimura H, Takeda H, Inoue W, et al. Fibrinolysis in patients with diabetic nephropathy determined by plasmin-α2 plasmin inhibitor complexes in plasma. J Diabet Complications 1990; 4: 175-8.
5. Ohmoto K, Yamamoto S, Ideguchi S, Yamamoto R, Takatori K, Ohumi T, et al. Clinical significance of thrombin-antithrombin III complex and plasmin-α2 plasmin inhibitor complex in chronic liver diseases. In Japanese. Nihon Shokakibyo Gakkai Zasshi 1990; 87: 1837-45.
6. 2-plasmin inhibitor-plasmin complex in patients with rheumatic diseases: possible role of fibrinolytic mechanism in vasculitis. Arthritis Rheum 1989; 32: 1427-33.
7. Jinnin M, Ihn H, Yamane K, Asano Y, Yazawa N, Tamaki K,. Plasma plasmin-α2-plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertension. Rheumatology (Oxford) 2003; 42: 240-3.
8. Kanno Y, Kuroki A, Okada K, Tomogane K, Ueshima S, Matsuo O, et al. Alpha2-antiplasmin is involved in the production of transforming growth factor β1 and fibrosis. J Thromb Haemost 2007; 5: 2266-73.
9. Kanno Y, Kawashita E, Minamida M, Kaneiwa A, Okada K, Ueshima S, et al. Alpha2-antiplasmin is associated with the progression of fibrosis. Am J Pathol 2010; 176: 238-45.
10. Irving JA, Pike RN, Lesk AM, Whisstock JC,. Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res 2000; 10: 1845-64.
11. Law RH, Sofian T, Kan WT, Horvath AJ, Hitchen CR, Langendorf CG, et al. X-ray crystal structure of the fibrinolysis inhibitor α2-antiplasmin. Blood 2008; 111: 2049-52.
12. Tombran-Tink J, Aparicio S, Xu X, Tink AR, Lara N, Sawant S, et al. PEDF and the serpins: phylogeny, sequence conservation, and functional domains. J Struct Biol 2005; 151: 130-50.
13. Notari L, Baladron V, Aroca-Aguilar JD, Balko N, Heredia R, Meyer C, et al. Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor. J Biol Chem 2006; 281: 38022-37.
14. Ueno N, Takegoshi Y, Kamei D, Kudo I, Murakami M,. Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem Biophys Res Commun 2005; 338: 70-6.
15. 2 in bleomycin-induced pulmonary fibrosis. Nat Med 2002; 8: 480-4.
16. Hou X, Arvisais EW, Jiang C, Chen DB, Roy SK, Pate JL, et al. Prostaglandin F2α stimulates the expression and secretion of transforming growth factor B1 via induction of the early growth response 1 gene (EGR1) in the bovine corpus luteum. Mol Endocrinol 2008; 22: 403-14.
17. 2α receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-β. Nat Med 2009; 15: 1426-30.
18. Okada K, Lijnen HR, Dewerchin M, Belayew A, Matsuo O, Collen D, et al. Characterization and targeting of the murine α2-antiplasmin gene. Thromb Haemost 1997; 78: 1104-10.
19. Lijnen HR, Okada K, Matsuo O, Collen D, Dewerchin M,. Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding. Blood 1999; 93: 2274-81.
20. Kanno Y, Hirade K, Ishisaki A, Nakajima K, Suga H, Into T, et al. Lack of α2-antiplasmin improves cutaneous wound healing via over-released vascular endothelial growth factor-induced angiogenesis in wound lesions. J Thromb Haemost 2006; 4: 1602-10.
21. Kanno Y, Into T, Lowenstein CJ, Matsushita K,. Nitric oxide regulates vascular calcification by interfering with TGF-β signalling. Cardiovasc Res 2008; 77: 221-30.
22. Kanno Y, Kaneiwa A, Minamida M, Kanno M, Tomogane K, Takeuchi K, et al. The absence of uPAR is associated with the progression of dermal fibrosis. J Invest Dermatol 2008; 128: 2792-7.
23. Junqueira LC, Bignolas G, Brentani RR,. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979; 11: 447-55.
24. Smani T, Zakharov SI, Csutora P, Leno E, Trepakova ES, Bolotina VM,. A novel mechanism for the store-operated calcium influx pathway. Nat Cell Biol 2004; 6: 113-20.
25. Kim SC, Chen Y, Mirza S, Xu Y, Lee J, Liu P, et al. A clean, more efficient method for in-solution digestion of protein mixtures without detergent or urea. J Proteome Res 2006; 5: 3446-52.
26. Tithof PK, Roberts MP, Guan W, Elgayyar M, Godkin JD,. Distinct phospholipase A2 enzymes regulate prostaglandin E2 and F2α production by bovine endometrial epithelial cells. Reprod Biol Endocrinol 2007; 5: 16.
27. 2α (FP) receptor. J Pharmacol Exp Ther 1999; 290: 1278-84.
28. Zhang SX, Wang JJ, Gao G, Parke K, Ma JX,. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. J Mol Endocrinol 2006; 37: 1-12.
29. Ek ET, Dass CR, Choong PF,. Pigment epithelium-derived factor: a multimodal tumor inhibitor. Mol Cancer Ther 2006; 5: 1641-6.
30. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999; 285: 245-8.
31. Cosgrove GP, Brown KK, Schiemann WP, Serls AE, Parr JE, Geraci MW, et al. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis. Am J Respir Crit Care Med 2004; 170: 242-51.
32. 2α receptor mediated activation of MEK/ERK-CREB cascade. FEBS J 2011; 278: 2901-12.
33. 2α activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element. Mol Cell Endocrinol 2008; 285: 51-61.
34. Parks WC, Mecham RP,. Matrix metalloproteinases. San Diego: Academic Press; 1998. p. 1-14.
35. 2 synthesis in humans and mice. J Clin Invest 2010; 120: 1950-60.
36. Hattori N, Mizuno S, Yoshida Y, Chin K, Mishima M, Sisson TH,. The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism. Am J Pathol 2004; 164: 1091-8.
37. Sisson TH, Hanson KE, Subbotina N, Patwardhan A, Hattori N, Simon RH,. Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2002; 283: L1023-32.
38. Sisson TH, Hattori N, Xu Y, Simon RH,. Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes. Hum Gene Ther 1999; 10: 2315-23.
39. Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, et al. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 1996; 97: 232-7.